ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 15 filers reported holding ACORDA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $20,000 | +81.8% | 20,000 | 0.0% | 0.01% | +60.0% |
| Q4 2020 | $11,000 | -35.3% | 20,000 | 0.0% | 0.01% | -44.4% |
| Q3 2020 | $17,000 | 0.0% | 20,000 | 0.0% | 0.01% | -18.2% |
| Q2 2020 | $17,000 | 0.0% | 20,000 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $17,000 | +13.3% | 20,000 | 0.0% | 0.01% | +22.2% |
| Q4 2019 | $15,000 | -6.2% | 20,000 | 0.0% | 0.01% | -18.2% |
| Q3 2019 | $16,000 | -5.9% | 20,000 | 0.0% | 0.01% | -8.3% |
| Q2 2019 | $17,000 | -5.6% | 20,000 | 0.0% | 0.01% | -7.7% |
| Q1 2019 | $18,000 | +5.9% | 20,000 | 0.0% | 0.01% | +8.3% |
| Q4 2018 | $17,000 | 0.0% | 20,000 | 0.0% | 0.01% | +9.1% |
| Q3 2018 | $17,000 | – | 20,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYMPHONY ASSET MANAGEMENT LLC | 23,872,000 | $18,748,000 | 4.04% |
| PFM Health Sciences, LP | 49,764,825 | $39,319,000 | 1.16% |
| Partner Investment Management, L.P. | 659,175 | $521,000 | 0.89% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 40,000,000 | $31,402,000,000 | 0.87% |
| Bruce & Co., Inc. | 6,000,000 | $4,200,000 | 0.87% |
| CANYON CAPITAL ADVISORS LLC | 36,500,000 | $28,747,000 | 0.62% |
| PenderFund Capital Management Ltd. | 2,000,000 | $1,571,000 | 0.53% |
| Shaolin Capital Management LLC | 4,000,000 | $3,136,000 | 0.48% |
| Castle Creek Arbitrage, LLC | 2,310,000 | $1,815,000 | 0.46% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 5,500,000 | $4,368,000 | 0.27% |